カテゴリ： 世界, 医療/バイオ, QYResearch

注射用ヒアルロン酸＆ボツリヌス毒素の世界市場2023年：注射用ヒアルロン酸、ボツリヌス毒素

■ 英語タイトル：Global Injectable Hyaluronic Acid and Botulinum Toxin Market Research Report 2023

調査会社QYResearch社が発行したリサーチレポート（データ管理コード：QYR23MA8796）■ 発行会社/調査会社：QYResearch
■ 商品コード：QYR23MA8796
■ 発行日：2023年3月
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：112
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥440,800見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD4,350 ⇒換算￥661,200見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD5,800 ⇒換算￥881,600見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[注射用ヒアルロン酸＆ボツリヌス毒素の世界市場2023年：注射用ヒアルロン酸、ボツリヌス毒素]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

本調査資料は注射用ヒアルロン酸＆ボツリヌス毒素のグローバル市場について調査・分析し、世界の注射用ヒアルロン酸＆ボツリヌス毒素市場概要、メーカー別競争状況、地域別市場規模、タイプ別セグメント分析（注射用ヒアルロン酸、ボツリヌス毒素）、用途別セグメント分析（化粧品、医療）、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、AbbVie、Galderma、LG Life Sciences、Merz、Medytox、Hugel、Croma-Pharma、Beijing IMEIK、Bloomage Bio、Elravie (Humedix)、Cleviel (Pharma Research Products)、Haohai Biological、Teoxane、Sinclair、Suneva Medical、CG Bio、SciVision Biotech、Prollenium、Bohus BioTech、Caregen、Ipsen、LIBP、US World Meds、Daewoong、JETEMAなどが含まれています。注射用ヒアルロン酸＆ボツリヌス毒素のグローバル市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。新型コロナとロシア・ウクライナ戦争の影響は、注射用ヒアルロン酸＆ボツリヌス毒素市場規模を算出する際に考慮しました。

・注射用ヒアルロン酸＆ボツリヌス毒素市場の概要
- 製品の定義
- 注射用ヒアルロン酸＆ボツリヌス毒素の種類別セグメント
- 世界の注射用ヒアルロン酸＆ボツリヌス毒素市場規模：タイプ別分析（注射用ヒアルロン酸、ボツリヌス毒素）
- 注射用ヒアルロン酸＆ボツリヌス毒素の用途別セグメント
- 世界の注射用ヒアルロン酸＆ボツリヌス毒素市場規模：用途別分析（化粧品、医療）
- 世界の注射用ヒアルロン酸＆ボツリヌス毒素市場規模予測（2018年-2029年）
- 注射用ヒアルロン酸＆ボツリヌス毒素の平均価格推移（2018年-2029年）
- 前提条件と制限事項

・メーカー別競争状況
- メーカー別市場シェア
- 世界の主要メーカー、業界ランキング分析
- メーカー別平均価格
- 注射用ヒアルロン酸＆ボツリヌス毒素市場の競争状況およびトレンド

・注射用ヒアルロン酸＆ボツリヌス毒素の地域別市場規模
- 北米の注射用ヒアルロン酸＆ボツリヌス毒素市場規模（2018年-2029年）
- 米国の注射用ヒアルロン酸＆ボツリヌス毒素市場規模（2018年-2029年）
- ヨーロッパの注射用ヒアルロン酸＆ボツリヌス毒素市場規模（2018年-2029年）
- アジア太平洋の注射用ヒアルロン酸＆ボツリヌス毒素市場規模（2018年-2029年）
- 中国の注射用ヒアルロン酸＆ボツリヌス毒素市場規模（2018年-2029年）
- 日本の注射用ヒアルロン酸＆ボツリヌス毒素市場規模（2018年-2029年）
- 韓国の注射用ヒアルロン酸＆ボツリヌス毒素市場規模（2018年-2029年）
- インドの注射用ヒアルロン酸＆ボツリヌス毒素市場規模（2018年-2029年）
- オーストラリアの注射用ヒアルロン酸＆ボツリヌス毒素市場規模（2018年-2029年）
- 中南米の注射用ヒアルロン酸＆ボツリヌス毒素市場規模（2018年-2029年）
- 中東・アフリカの注射用ヒアルロン酸＆ボツリヌス毒素市場規模（2018年-2029年）

・種類別セグメント：注射用ヒアルロン酸、ボツリヌス毒素
- 世界の注射用ヒアルロン酸＆ボツリヌス毒素のタイプ別販売量（2018年-2023年）
- 世界の注射用ヒアルロン酸＆ボツリヌス毒素のタイプ別売上（2018年-2023年）
- 世界の注射用ヒアルロン酸＆ボツリヌス毒素のタイプ別価格

・用途別セグメント：化粧品、医療
- 世界の注射用ヒアルロン酸＆ボツリヌス毒素の用途別販売量（2018年-2023年）
- 世界の注射用ヒアルロン酸＆ボツリヌス毒素の用途別売上（2018年-2023年）
- 世界の注射用ヒアルロン酸＆ボツリヌス毒素の用途別価格

・主要企業のプロファイル：企業情報、事業概要、売上、製品ポートフォリオ、動向
AbbVie、Galderma、LG Life Sciences、Merz、Medytox、Hugel、Croma-Pharma、Beijing IMEIK、Bloomage Bio、Elravie (Humedix)、Cleviel (Pharma Research Products)、Haohai Biological、Teoxane、Sinclair、Suneva Medical、CG Bio、SciVision Biotech、Prollenium、Bohus BioTech、Caregen、Ipsen、LIBP、US World Meds、Daewoong、JETEMA

・産業チェーンと販売チャネルの分析
- 注射用ヒアルロン酸＆ボツリヌス毒素産業チェーン分析
- 注射用ヒアルロン酸＆ボツリヌス毒素の主要原材料
- 注射用ヒアルロン酸＆ボツリヌス毒素の販売チャネル
- 注射用ヒアルロン酸＆ボツリヌス毒素のディストリビューター
- 注射用ヒアルロン酸＆ボツリヌス毒素の主要顧客

・注射用ヒアルロン酸＆ボツリヌス毒素市場ダイナミクス
- 注射用ヒアルロン酸＆ボツリヌス毒素の業界動向
- 注射用ヒアルロン酸＆ボツリヌス毒素市場の成長ドライバ、課題、阻害要因

・調査の結論

・調査手法と情報源

Dermal fillers can be very helpful in those with early signs of aging, or as a value-added part of facial rejuvenation surgery. Botulinum toxin (BTX) is a neurotoxic protein produced by the bacterium Clostridium botulinum and related species. It prevents the release of the neurotransmitter acetylcholine from axon endings at the neuromuscular junction and thus causes flaccid paralysis. Infection with the bacterium causes the disease botulism. The toxin is also used commercially in medicine, cosmetics and research.
Highlights
The global Injectable Hyaluronic Acid and Botulinum Toxin market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Injectable Hyaluronic Acid and Botulinum Toxin is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Injectable Hyaluronic Acid and Botulinum Toxin is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Injectable Hyaluronic Acid and Botulinum Toxin include AbbVie, Galderma, LG Life Sciences, Merz, Medytox, Hugel, Croma-Pharma, Beijing IMEIK and Bloomage Bio, etc. in 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Injectable Hyaluronic Acid and Botulinum Toxin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Injectable Hyaluronic Acid and Botulinum Toxin.
The Injectable Hyaluronic Acid and Botulinum Toxin market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Injectable Hyaluronic Acid and Botulinum Toxin market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Injectable Hyaluronic Acid and Botulinum Toxin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
AbbVie
Galderma
LG Life Sciences
Merz
Medytox
Hugel
Croma-Pharma
Beijing IMEIK
Bloomage Bio
Elravie (Humedix)
Cleviel (Pharma Research Products)
Haohai Biological
Teoxane
Sinclair
Suneva Medical
CG Bio
SciVision Biotech
Prollenium
Bohus BioTech
Caregen
Ipsen
LIBP
US World Meds
Daewoong
JETEMA
Segment by Type
Injectable Hyaluronic Acid
Botulinum Toxin
Segment by Application
Cosmetic
Medical
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Injectable Hyaluronic Acid and Botulinum Toxin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Injectable Hyaluronic Acid and Botulinum Toxin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Injectable Hyaluronic Acid and Botulinum Toxin Market Overview
1.1 Product Overview and Scope of Injectable Hyaluronic Acid and Botulinum Toxin
1.2 Injectable Hyaluronic Acid and Botulinum Toxin Segment by Type
1.2.1 Global Injectable Hyaluronic Acid and Botulinum Toxin Market Value Comparison by Type (2023-2029)
1.2.2 Injectable Hyaluronic Acid
1.2.3 Botulinum Toxin
1.3 Injectable Hyaluronic Acid and Botulinum Toxin Segment by Application
1.3.1 Global Injectable Hyaluronic Acid and Botulinum Toxin Market Value by Application: (2023-2029)
1.3.2 Cosmetic
1.3.3 Medical
1.4 Global Injectable Hyaluronic Acid and Botulinum Toxin Market Size Estimates and Forecasts
1.4.1 Global Injectable Hyaluronic Acid and Botulinum Toxin Revenue 2018-2029
1.4.2 Global Injectable Hyaluronic Acid and Botulinum Toxin Sales 2018-2029
1.4.3 Global Injectable Hyaluronic Acid and Botulinum Toxin Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Injectable Hyaluronic Acid and Botulinum Toxin Market Competition by Manufacturers
2.1 Global Injectable Hyaluronic Acid and Botulinum Toxin Sales Market Share by Manufacturers (2018-2023)
2.2 Global Injectable Hyaluronic Acid and Botulinum Toxin Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Injectable Hyaluronic Acid and Botulinum Toxin Average Price by Manufacturers (2018-2023)
2.4 Global Injectable Hyaluronic Acid and Botulinum Toxin Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Injectable Hyaluronic Acid and Botulinum Toxin, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Injectable Hyaluronic Acid and Botulinum Toxin, Product Type & Application
2.7 Injectable Hyaluronic Acid and Botulinum Toxin Market Competitive Situation and Trends
2.7.1 Injectable Hyaluronic Acid and Botulinum Toxin Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Injectable Hyaluronic Acid and Botulinum Toxin Players Market Share by Revenue
2.7.3 Global Injectable Hyaluronic Acid and Botulinum Toxin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Injectable Hyaluronic Acid and Botulinum Toxin Retrospective Market Scenario by Region
3.1 Global Injectable Hyaluronic Acid and Botulinum Toxin Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Injectable Hyaluronic Acid and Botulinum Toxin Global Injectable Hyaluronic Acid and Botulinum Toxin Sales by Region: 2018-2029
3.2.1 Global Injectable Hyaluronic Acid and Botulinum Toxin Sales by Region: 2018-2023
3.2.2 Global Injectable Hyaluronic Acid and Botulinum Toxin Sales by Region: 2024-2029
3.3 Global Injectable Hyaluronic Acid and Botulinum Toxin Global Injectable Hyaluronic Acid and Botulinum Toxin Revenue by Region: 2018-2029
3.3.1 Global Injectable Hyaluronic Acid and Botulinum Toxin Revenue by Region: 2018-2023
3.3.2 Global Injectable Hyaluronic Acid and Botulinum Toxin Revenue by Region: 2024-2029
3.4 North America Injectable Hyaluronic Acid and Botulinum Toxin Market Facts & Figures by Country
3.4.1 North America Injectable Hyaluronic Acid and Botulinum Toxin Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Injectable Hyaluronic Acid and Botulinum Toxin Sales by Country (2018-2029)
3.4.3 North America Injectable Hyaluronic Acid and Botulinum Toxin Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Injectable Hyaluronic Acid and Botulinum Toxin Market Facts & Figures by Country
3.5.1 Europe Injectable Hyaluronic Acid and Botulinum Toxin Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Injectable Hyaluronic Acid and Botulinum Toxin Sales by Country (2018-2029)
3.5.3 Europe Injectable Hyaluronic Acid and Botulinum Toxin Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Injectable Hyaluronic Acid and Botulinum Toxin Market Facts & Figures by Country
3.6.1 Asia Pacific Injectable Hyaluronic Acid and Botulinum Toxin Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Injectable Hyaluronic Acid and Botulinum Toxin Sales by Country (2018-2029)
3.6.3 Asia Pacific Injectable Hyaluronic Acid and Botulinum Toxin Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Injectable Hyaluronic Acid and Botulinum Toxin Market Facts & Figures by Country
3.7.1 Latin America Injectable Hyaluronic Acid and Botulinum Toxin Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Injectable Hyaluronic Acid and Botulinum Toxin Sales by Country (2018-2029)
3.7.3 Latin America Injectable Hyaluronic Acid and Botulinum Toxin Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Injectable Hyaluronic Acid and Botulinum Toxin Market Facts & Figures by Country
3.8.1 Middle East and Africa Injectable Hyaluronic Acid and Botulinum Toxin Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Injectable Hyaluronic Acid and Botulinum Toxin Sales by Country (2018-2029)
3.8.3 Middle East and Africa Injectable Hyaluronic Acid and Botulinum Toxin Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Injectable Hyaluronic Acid and Botulinum Toxin Sales by Type (2018-2029)
4.1.1 Global Injectable Hyaluronic Acid and Botulinum Toxin Sales by Type (2018-2023)
4.1.2 Global Injectable Hyaluronic Acid and Botulinum Toxin Sales by Type (2024-2029)
4.1.3 Global Injectable Hyaluronic Acid and Botulinum Toxin Sales Market Share by Type (2018-2029)
4.2 Global Injectable Hyaluronic Acid and Botulinum Toxin Revenue by Type (2018-2029)
4.2.1 Global Injectable Hyaluronic Acid and Botulinum Toxin Revenue by Type (2018-2023)
4.2.2 Global Injectable Hyaluronic Acid and Botulinum Toxin Revenue by Type (2024-2029)
4.2.3 Global Injectable Hyaluronic Acid and Botulinum Toxin Revenue Market Share by Type (2018-2029)
4.3 Global Injectable Hyaluronic Acid and Botulinum Toxin Price by Type (2018-2029)
5 Segment by Application
5.1 Global Injectable Hyaluronic Acid and Botulinum Toxin Sales by Application (2018-2029)
5.1.1 Global Injectable Hyaluronic Acid and Botulinum Toxin Sales by Application (2018-2023)
5.1.2 Global Injectable Hyaluronic Acid and Botulinum Toxin Sales by Application (2024-2029)
5.1.3 Global Injectable Hyaluronic Acid and Botulinum Toxin Sales Market Share by Application (2018-2029)
5.2 Global Injectable Hyaluronic Acid and Botulinum Toxin Revenue by Application (2018-2029)
5.2.1 Global Injectable Hyaluronic Acid and Botulinum Toxin Revenue by Application (2018-2023)
5.2.2 Global Injectable Hyaluronic Acid and Botulinum Toxin Revenue by Application (2024-2029)
5.2.3 Global Injectable Hyaluronic Acid and Botulinum Toxin Revenue Market Share by Application (2018-2029)
5.3 Global Injectable Hyaluronic Acid and Botulinum Toxin Price by Application (2018-2029)
6 Key Companies Profiled
6.1 AbbVie
6.1.1 AbbVie Corporation Information
6.1.2 AbbVie Description and Business Overview
6.1.3 AbbVie Injectable Hyaluronic Acid and Botulinum Toxin Sales, Revenue and Gross Margin (2018-2023)
6.1.4 AbbVie Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio
6.1.5 AbbVie Recent Developments/Updates
6.2 Galderma
6.2.1 Galderma Corporation Information
6.2.2 Galderma Description and Business Overview
6.2.3 Galderma Injectable Hyaluronic Acid and Botulinum Toxin Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Galderma Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio
6.2.5 Galderma Recent Developments/Updates
6.3 LG Life Sciences
6.3.1 LG Life Sciences Corporation Information
6.3.2 LG Life Sciences Description and Business Overview
6.3.3 LG Life Sciences Injectable Hyaluronic Acid and Botulinum Toxin Sales, Revenue and Gross Margin (2018-2023)
6.3.4 LG Life Sciences Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio
6.3.5 LG Life Sciences Recent Developments/Updates
6.4 Merz
6.4.1 Merz Corporation Information
6.4.2 Merz Description and Business Overview
6.4.3 Merz Injectable Hyaluronic Acid and Botulinum Toxin Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Merz Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio
6.4.5 Merz Recent Developments/Updates
6.5 Medytox
6.5.1 Medytox Corporation Information
6.5.2 Medytox Description and Business Overview
6.5.3 Medytox Injectable Hyaluronic Acid and Botulinum Toxin Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Medytox Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio
6.5.5 Medytox Recent Developments/Updates
6.6 Hugel
6.6.1 Hugel Corporation Information
6.6.2 Hugel Description and Business Overview
6.6.3 Hugel Injectable Hyaluronic Acid and Botulinum Toxin Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Hugel Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio
6.6.5 Hugel Recent Developments/Updates
6.7 Croma-Pharma
6.6.1 Croma-Pharma Corporation Information
6.6.2 Croma-Pharma Description and Business Overview
6.6.3 Croma-Pharma Injectable Hyaluronic Acid and Botulinum Toxin Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Croma-Pharma Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio
6.7.5 Croma-Pharma Recent Developments/Updates
6.8 Beijing IMEIK
6.8.1 Beijing IMEIK Corporation Information
6.8.2 Beijing IMEIK Description and Business Overview
6.8.3 Beijing IMEIK Injectable Hyaluronic Acid and Botulinum Toxin Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Beijing IMEIK Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio
6.8.5 Beijing IMEIK Recent Developments/Updates
6.9 Bloomage Bio
6.9.1 Bloomage Bio Corporation Information
6.9.2 Bloomage Bio Description and Business Overview
6.9.3 Bloomage Bio Injectable Hyaluronic Acid and Botulinum Toxin Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Bloomage Bio Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio
6.9.5 Bloomage Bio Recent Developments/Updates
6.10 Elravie (Humedix)
6.10.1 Elravie (Humedix) Corporation Information
6.10.2 Elravie (Humedix) Description and Business Overview
6.10.3 Elravie (Humedix) Injectable Hyaluronic Acid and Botulinum Toxin Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Elravie (Humedix) Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio
6.10.5 Elravie (Humedix) Recent Developments/Updates
6.11 Cleviel (Pharma Research Products)
6.11.1 Cleviel (Pharma Research Products) Corporation Information
6.11.2 Cleviel (Pharma Research Products) Injectable Hyaluronic Acid and Botulinum Toxin Description and Business Overview
6.11.3 Cleviel (Pharma Research Products) Injectable Hyaluronic Acid and Botulinum Toxin Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Cleviel (Pharma Research Products) Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio
6.11.5 Cleviel (Pharma Research Products) Recent Developments/Updates
6.12 Haohai Biological
6.12.1 Haohai Biological Corporation Information
6.12.2 Haohai Biological Injectable Hyaluronic Acid and Botulinum Toxin Description and Business Overview
6.12.3 Haohai Biological Injectable Hyaluronic Acid and Botulinum Toxin Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Haohai Biological Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio
6.12.5 Haohai Biological Recent Developments/Updates
6.13 Teoxane
6.13.1 Teoxane Corporation Information
6.13.2 Teoxane Injectable Hyaluronic Acid and Botulinum Toxin Description and Business Overview
6.13.3 Teoxane Injectable Hyaluronic Acid and Botulinum Toxin Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Teoxane Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio
6.13.5 Teoxane Recent Developments/Updates
6.14 Sinclair
6.14.1 Sinclair Corporation Information
6.14.2 Sinclair Injectable Hyaluronic Acid and Botulinum Toxin Description and Business Overview
6.14.3 Sinclair Injectable Hyaluronic Acid and Botulinum Toxin Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Sinclair Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio
6.14.5 Sinclair Recent Developments/Updates
6.15 Suneva Medical
6.15.1 Suneva Medical Corporation Information
6.15.2 Suneva Medical Injectable Hyaluronic Acid and Botulinum Toxin Description and Business Overview
6.15.3 Suneva Medical Injectable Hyaluronic Acid and Botulinum Toxin Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Suneva Medical Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio
6.15.5 Suneva Medical Recent Developments/Updates
6.16 CG Bio
6.16.1 CG Bio Corporation Information
6.16.2 CG Bio Injectable Hyaluronic Acid and Botulinum Toxin Description and Business Overview
6.16.3 CG Bio Injectable Hyaluronic Acid and Botulinum Toxin Sales, Revenue and Gross Margin (2018-2023)
6.16.4 CG Bio Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio
6.16.5 CG Bio Recent Developments/Updates
6.17 SciVision Biotech
6.17.1 SciVision Biotech Corporation Information
6.17.2 SciVision Biotech Injectable Hyaluronic Acid and Botulinum Toxin Description and Business Overview
6.17.3 SciVision Biotech Injectable Hyaluronic Acid and Botulinum Toxin Sales, Revenue and Gross Margin (2018-2023)
6.17.4 SciVision Biotech Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio
6.17.5 SciVision Biotech Recent Developments/Updates
6.18 Prollenium
6.18.1 Prollenium Corporation Information
6.18.2 Prollenium Injectable Hyaluronic Acid and Botulinum Toxin Description and Business Overview
6.18.3 Prollenium Injectable Hyaluronic Acid and Botulinum Toxin Sales, Revenue and Gross Margin (2018-2023)
6.18.4 Prollenium Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio
6.18.5 Prollenium Recent Developments/Updates
6.19 Bohus BioTech
6.19.1 Bohus BioTech Corporation Information
6.19.2 Bohus BioTech Injectable Hyaluronic Acid and Botulinum Toxin Description and Business Overview
6.19.3 Bohus BioTech Injectable Hyaluronic Acid and Botulinum Toxin Sales, Revenue and Gross Margin (2018-2023)
6.19.4 Bohus BioTech Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio
6.19.5 Bohus BioTech Recent Developments/Updates
6.20 Caregen
6.20.1 Caregen Corporation Information
6.20.2 Caregen Injectable Hyaluronic Acid and Botulinum Toxin Description and Business Overview
6.20.3 Caregen Injectable Hyaluronic Acid and Botulinum Toxin Sales, Revenue and Gross Margin (2018-2023)
6.20.4 Caregen Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio
6.20.5 Caregen Recent Developments/Updates
6.21 Ipsen
6.21.1 Ipsen Corporation Information
6.21.2 Ipsen Injectable Hyaluronic Acid and Botulinum Toxin Description and Business Overview
6.21.3 Ipsen Injectable Hyaluronic Acid and Botulinum Toxin Sales, Revenue and Gross Margin (2018-2023)
6.21.4 Ipsen Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio
6.21.5 Ipsen Recent Developments/Updates
6.22 LIBP
6.22.1 LIBP Corporation Information
6.22.2 LIBP Injectable Hyaluronic Acid and Botulinum Toxin Description and Business Overview
6.22.3 LIBP Injectable Hyaluronic Acid and Botulinum Toxin Sales, Revenue and Gross Margin (2018-2023)
6.22.4 LIBP Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio
6.22.5 LIBP Recent Developments/Updates
6.23 US World Meds
6.23.1 US World Meds Corporation Information
6.23.2 US World Meds Injectable Hyaluronic Acid and Botulinum Toxin Description and Business Overview
6.23.3 US World Meds Injectable Hyaluronic Acid and Botulinum Toxin Sales, Revenue and Gross Margin (2018-2023)
6.23.4 US World Meds Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio
6.23.5 US World Meds Recent Developments/Updates
6.24 Daewoong
6.24.1 Daewoong Corporation Information
6.24.2 Daewoong Injectable Hyaluronic Acid and Botulinum Toxin Description and Business Overview
6.24.3 Daewoong Injectable Hyaluronic Acid and Botulinum Toxin Sales, Revenue and Gross Margin (2018-2023)
6.24.4 Daewoong Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio
6.24.5 Daewoong Recent Developments/Updates
6.25 JETEMA
6.25.1 JETEMA Corporation Information
6.25.2 JETEMA Injectable Hyaluronic Acid and Botulinum Toxin Description and Business Overview
6.25.3 JETEMA Injectable Hyaluronic Acid and Botulinum Toxin Sales, Revenue and Gross Margin (2018-2023)
6.25.4 JETEMA Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio
6.25.5 JETEMA Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Injectable Hyaluronic Acid and Botulinum Toxin Industry Chain Analysis
7.2 Injectable Hyaluronic Acid and Botulinum Toxin Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Injectable Hyaluronic Acid and Botulinum Toxin Production Mode & Process
7.4 Injectable Hyaluronic Acid and Botulinum Toxin Sales and Marketing
7.4.1 Injectable Hyaluronic Acid and Botulinum Toxin Sales Channels
7.4.2 Injectable Hyaluronic Acid and Botulinum Toxin Distributors
7.5 Injectable Hyaluronic Acid and Botulinum Toxin Customers
8 Injectable Hyaluronic Acid and Botulinum Toxin Market Dynamics
8.1 Injectable Hyaluronic Acid and Botulinum Toxin Industry Trends
8.2 Injectable Hyaluronic Acid and Botulinum Toxin Market Drivers
8.3 Injectable Hyaluronic Acid and Botulinum Toxin Market Challenges
8.4 Injectable Hyaluronic Acid and Botulinum Toxin Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Tables
Table 1. Global Injectable Hyaluronic Acid and Botulinum Toxin Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Injectable Hyaluronic Acid and Botulinum Toxin Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Injectable Hyaluronic Acid and Botulinum Toxin Market Competitive Situation by Manufacturers in 2022
Table 4. Global Injectable Hyaluronic Acid and Botulinum Toxin Sales (Units) of Key Manufacturers (2018-2023)
Table 5. Global Injectable Hyaluronic Acid and Botulinum Toxin Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Injectable Hyaluronic Acid and Botulinum Toxin Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Injectable Hyaluronic Acid and Botulinum Toxin Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Injectable Hyaluronic Acid and Botulinum Toxin Average Price (US$/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Injectable Hyaluronic Acid and Botulinum Toxin, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Injectable Hyaluronic Acid and Botulinum Toxin, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Injectable Hyaluronic Acid and Botulinum Toxin, Product Type & Application
Table 12. Global Key Manufacturers of Injectable Hyaluronic Acid and Botulinum Toxin, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Injectable Hyaluronic Acid and Botulinum Toxin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Injectable Hyaluronic Acid and Botulinum Toxin as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Injectable Hyaluronic Acid and Botulinum Toxin Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Injectable Hyaluronic Acid and Botulinum Toxin Sales by Region (2018-2023) & (Units)
Table 18. Global Injectable Hyaluronic Acid and Botulinum Toxin Sales Market Share by Region (2018-2023)
Table 19. Global Injectable Hyaluronic Acid and Botulinum Toxin Sales by Region (2024-2029) & (Units)
Table 20. Global Injectable Hyaluronic Acid and Botulinum Toxin Sales Market Share by Region (2024-2029)
Table 21. Global Injectable Hyaluronic Acid and Botulinum Toxin Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Injectable Hyaluronic Acid and Botulinum Toxin Revenue Market Share by Region (2018-2023)
Table 23. Global Injectable Hyaluronic Acid and Botulinum Toxin Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Injectable Hyaluronic Acid and Botulinum Toxin Revenue Market Share by Region (2024-2029)
Table 25. North America Injectable Hyaluronic Acid and Botulinum Toxin Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Injectable Hyaluronic Acid and Botulinum Toxin Sales by Country (2018-2023) & (Units)
Table 27. North America Injectable Hyaluronic Acid and Botulinum Toxin Sales by Country (2024-2029) & (Units)
Table 28. North America Injectable Hyaluronic Acid and Botulinum Toxin Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Injectable Hyaluronic Acid and Botulinum Toxin Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Injectable Hyaluronic Acid and Botulinum Toxin Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Injectable Hyaluronic Acid and Botulinum Toxin Sales by Country (2018-2023) & (Units)
Table 32. Europe Injectable Hyaluronic Acid and Botulinum Toxin Sales by Country (2024-2029) & (Units)
Table 33. Europe Injectable Hyaluronic Acid and Botulinum Toxin Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Injectable Hyaluronic Acid and Botulinum Toxin Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Injectable Hyaluronic Acid and Botulinum Toxin Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Injectable Hyaluronic Acid and Botulinum Toxin Sales by Region (2018-2023) & (Units)
Table 37. Asia Pacific Injectable Hyaluronic Acid and Botulinum Toxin Sales by Region (2024-2029) & (Units)
Table 38. Asia Pacific Injectable Hyaluronic Acid and Botulinum Toxin Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Injectable Hyaluronic Acid and Botulinum Toxin Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Injectable Hyaluronic Acid and Botulinum Toxin Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Injectable Hyaluronic Acid and Botulinum Toxin Sales by Country (2018-2023) & (Units)
Table 42. Latin America Injectable Hyaluronic Acid and Botulinum Toxin Sales by Country (2024-2029) & (Units)
Table 43. Latin America Injectable Hyaluronic Acid and Botulinum Toxin Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Injectable Hyaluronic Acid and Botulinum Toxin Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Injectable Hyaluronic Acid and Botulinum Toxin Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Injectable Hyaluronic Acid and Botulinum Toxin Sales by Country (2018-2023) & (Units)
Table 47. Middle East & Africa Injectable Hyaluronic Acid and Botulinum Toxin Sales by Country (2024-2029) & (Units)
Table 48. Middle East & Africa Injectable Hyaluronic Acid and Botulinum Toxin Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Injectable Hyaluronic Acid and Botulinum Toxin Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Injectable Hyaluronic Acid and Botulinum Toxin Sales (Units) by Type (2018-2023)
Table 51. Global Injectable Hyaluronic Acid and Botulinum Toxin Sales (Units) by Type (2024-2029)
Table 52. Global Injectable Hyaluronic Acid and Botulinum Toxin Sales Market Share by Type (2018-2023)
Table 53. Global Injectable Hyaluronic Acid and Botulinum Toxin Sales Market Share by Type (2024-2029)
Table 54. Global Injectable Hyaluronic Acid and Botulinum Toxin Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Injectable Hyaluronic Acid and Botulinum Toxin Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Injectable Hyaluronic Acid and Botulinum Toxin Revenue Market Share by Type (2018-2023)
Table 57. Global Injectable Hyaluronic Acid and Botulinum Toxin Revenue Market Share by Type (2024-2029)
Table 58. Global Injectable Hyaluronic Acid and Botulinum Toxin Price (US$/Unit) by Type (2018-2023)
Table 59. Global Injectable Hyaluronic Acid and Botulinum Toxin Price (US$/Unit) by Type (2024-2029)
Table 60. Global Injectable Hyaluronic Acid and Botulinum Toxin Sales (Units) by Application (2018-2023)
Table 61. Global Injectable Hyaluronic Acid and Botulinum Toxin Sales (Units) by Application (2024-2029)
Table 62. Global Injectable Hyaluronic Acid and Botulinum Toxin Sales Market Share by Application (2018-2023)
Table 63. Global Injectable Hyaluronic Acid and Botulinum Toxin Sales Market Share by Application (2024-2029)
Table 64. Global Injectable Hyaluronic Acid and Botulinum Toxin Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Injectable Hyaluronic Acid and Botulinum Toxin Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Injectable Hyaluronic Acid and Botulinum Toxin Revenue Market Share by Application (2018-2023)
Table 67. Global Injectable Hyaluronic Acid and Botulinum Toxin Revenue Market Share by Application (2024-2029)
Table 68. Global Injectable Hyaluronic Acid and Botulinum Toxin Price (US$/Unit) by Application (2018-2023)
Table 69. Global Injectable Hyaluronic Acid and Botulinum Toxin Price (US$/Unit) by Application (2024-2029)
Table 70. AbbVie Corporation Information
Table 71. AbbVie Description and Business Overview
Table 72. AbbVie Injectable Hyaluronic Acid and Botulinum Toxin Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 73. AbbVie Injectable Hyaluronic Acid and Botulinum Toxin Product
Table 74. AbbVie Recent Developments/Updates
Table 75. Galderma Corporation Information
Table 76. Galderma Description and Business Overview
Table 77. Galderma Injectable Hyaluronic Acid and Botulinum Toxin Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 78. Galderma Injectable Hyaluronic Acid and Botulinum Toxin Product
Table 79. Galderma Recent Developments/Updates
Table 80. LG Life Sciences Corporation Information
Table 81. LG Life Sciences Description and Business Overview
Table 82. LG Life Sciences Injectable Hyaluronic Acid and Botulinum Toxin Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. LG Life Sciences Injectable Hyaluronic Acid and Botulinum Toxin Product
Table 84. LG Life Sciences Recent Developments/Updates
Table 85. Merz Corporation Information
Table 86. Merz Description and Business Overview
Table 87. Merz Injectable Hyaluronic Acid and Botulinum Toxin Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Merz Injectable Hyaluronic Acid and Botulinum Toxin Product
Table 89. Merz Recent Developments/Updates
Table 90. Medytox Corporation Information
Table 91. Medytox Description and Business Overview
Table 92. Medytox Injectable Hyaluronic Acid and Botulinum Toxin Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Medytox Injectable Hyaluronic Acid and Botulinum Toxin Product
Table 94. Medytox Recent Developments/Updates
Table 95. Hugel Corporation Information
Table 96. Hugel Description and Business Overview
Table 97. Hugel Injectable Hyaluronic Acid and Botulinum Toxin Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Hugel Injectable Hyaluronic Acid and Botulinum Toxin Product
Table 99. Hugel Recent Developments/Updates
Table 100. Croma-Pharma Corporation Information
Table 101. Croma-Pharma Description and Business Overview
Table 102. Croma-Pharma Injectable Hyaluronic Acid and Botulinum Toxin Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Croma-Pharma Injectable Hyaluronic Acid and Botulinum Toxin Product
Table 104. Croma-Pharma Recent Developments/Updates
Table 105. Beijing IMEIK Corporation Information
Table 106. Beijing IMEIK Description and Business Overview
Table 107. Beijing IMEIK Injectable Hyaluronic Acid and Botulinum Toxin Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. Beijing IMEIK Injectable Hyaluronic Acid and Botulinum Toxin Product
Table 109. Beijing IMEIK Recent Developments/Updates
Table 110. Bloomage Bio Corporation Information
Table 111. Bloomage Bio Description and Business Overview
Table 112. Bloomage Bio Injectable Hyaluronic Acid and Botulinum Toxin Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. Bloomage Bio Injectable Hyaluronic Acid and Botulinum Toxin Product
Table 114. Bloomage Bio Recent Developments/Updates
Table 115. Elravie (Humedix) Corporation Information
Table 116. Elravie (Humedix) Description and Business Overview
Table 117. Elravie (Humedix) Injectable Hyaluronic Acid and Botulinum Toxin Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. Elravie (Humedix) Injectable Hyaluronic Acid and Botulinum Toxin Product
Table 119. Elravie (Humedix) Recent Developments/Updates
Table 120. Cleviel (Pharma Research Products) Corporation Information
Table 121. Cleviel (Pharma Research Products) Description and Business Overview
Table 122. Cleviel (Pharma Research Products) Injectable Hyaluronic Acid and Botulinum Toxin Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 123. Cleviel (Pharma Research Products) Injectable Hyaluronic Acid and Botulinum Toxin Product
Table 124. Cleviel (Pharma Research Products) Recent Developments/Updates
Table 125. Haohai Biological Corporation Information
Table 126. Haohai Biological Description and Business Overview
Table 127. Haohai Biological Injectable Hyaluronic Acid and Botulinum Toxin Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 128. Haohai Biological Injectable Hyaluronic Acid and Botulinum Toxin Product
Table 129. Haohai Biological Recent Developments/Updates
Table 130. Teoxane Corporation Information
Table 131. Teoxane Description and Business Overview
Table 132. Teoxane Injectable Hyaluronic Acid and Botulinum Toxin Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 133. Teoxane Injectable Hyaluronic Acid and Botulinum Toxin Product
Table 134. Teoxane Recent Developments/Updates
Table 135. Sinclair Corporation Information
Table 136. Sinclair Description and Business Overview
Table 137. Sinclair Injectable Hyaluronic Acid and Botulinum Toxin Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 138. Sinclair Injectable Hyaluronic Acid and Botulinum Toxin Product
Table 139. Sinclair Recent Developments/Updates
Table 140. Suneva Medical Corporation Information
Table 141. Suneva Medical Description and Business Overview
Table 142. Suneva Medical Injectable Hyaluronic Acid and Botulinum Toxin Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 143. Suneva Medical Injectable Hyaluronic Acid and Botulinum Toxin Product
Table 144. Suneva Medical Recent Developments/Updates
Table 145. CG Bio Corporation Information
Table 146. CG Bio Description and Business Overview
Table 147. CG Bio Injectable Hyaluronic Acid and Botulinum Toxin Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 148. CG Bio Injectable Hyaluronic Acid and Botulinum Toxin Product
Table 149. CG Bio Recent Developments/Updates
Table 150. SciVision Biotech Corporation Information
Table 151. SciVision Biotech Description and Business Overview
Table 152. SciVision Biotech Injectable Hyaluronic Acid and Botulinum Toxin Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 153. SciVision Biotech Injectable Hyaluronic Acid and Botulinum Toxin Product
Table 154. SciVision Biotech Recent Developments/Updates
Table 155. Prollenium Corporation Information
Table 156. Prollenium Description and Business Overview
Table 157. Prollenium Injectable Hyaluronic Acid and Botulinum Toxin Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 158. Prollenium Injectable Hyaluronic Acid and Botulinum Toxin Product
Table 159. Prollenium Recent Developments/Updates
Table 160. Bohus BioTech Corporation Information
Table 161. Bohus BioTech Description and Business Overview
Table 162. Bohus BioTech Injectable Hyaluronic Acid and Botulinum Toxin Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 163. Bohus BioTech Injectable Hyaluronic Acid and Botulinum Toxin Product
Table 164. Bohus BioTech Recent Developments/Updates
Table 165. Caregen Corporation Information
Table 166. Caregen Description and Business Overview
Table 167. Caregen Injectable Hyaluronic Acid and Botulinum Toxin Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 168. Caregen Injectable Hyaluronic Acid and Botulinum Toxin Product
Table 169. Caregen Recent Developments/Updates
Table 170. Ipsen Corporation Information
Table 171. Ipsen Description and Business Overview
Table 172. Ipsen Injectable Hyaluronic Acid and Botulinum Toxin Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 173. Ipsen Injectable Hyaluronic Acid and Botulinum Toxin Product
Table 174. Ipsen Recent Developments/Updates
Table 175. LIBP Corporation Information
Table 176. LIBP Description and Business Overview
Table 177. LIBP Injectable Hyaluronic Acid and Botulinum Toxin Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 178. LIBP Injectable Hyaluronic Acid and Botulinum Toxin Product
Table 179. LIBP Recent Developments/Updates
Table 180. US World Meds Corporation Information
Table 181. US World Meds Description and Business Overview
Table 182. US World Meds Injectable Hyaluronic Acid and Botulinum Toxin Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 183. US World Meds Injectable Hyaluronic Acid and Botulinum Toxin Product
Table 184. US World Meds Recent Developments/Updates
Table 185. Daewoong Corporation Information
Table 186. Daewoong Description and Business Overview
Table 187. Daewoong Injectable Hyaluronic Acid and Botulinum Toxin Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 188. Daewoong Injectable Hyaluronic Acid and Botulinum Toxin Product
Table 189. Daewoong Recent Developments/Updates
Table 190. JETEMA Corporation Information
Table 191. JETEMA Description and Business Overview
Table 192. JETEMA Injectable Hyaluronic Acid and Botulinum Toxin Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 193. JETEMA Injectable Hyaluronic Acid and Botulinum Toxin Product
Table 194. JETEMA Recent Developments/Updates
Table 195. Key Raw Materials Lists
Table 196. Raw Materials Key Suppliers Lists
Table 197. Injectable Hyaluronic Acid and Botulinum Toxin Distributors List
Table 198. Injectable Hyaluronic Acid and Botulinum Toxin Customers List
Table 199. Injectable Hyaluronic Acid and Botulinum Toxin Market Trends
Table 200. Injectable Hyaluronic Acid and Botulinum Toxin Market Drivers
Table 201. Injectable Hyaluronic Acid and Botulinum Toxin Market Challenges
Table 202. Injectable Hyaluronic Acid and Botulinum Toxin Market Restraints
Table 203. Research Programs/Design for This Report
Table 204. Key Data Information from Secondary Sources
Table 205. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Injectable Hyaluronic Acid and Botulinum Toxin
Figure 2. Global Injectable Hyaluronic Acid and Botulinum Toxin Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Injectable Hyaluronic Acid and Botulinum Toxin Market Share by Type in 2022 & 2029
Figure 4. Injectable Hyaluronic Acid Product Picture
Figure 5. Botulinum Toxin Product Picture
Figure 6. Global Injectable Hyaluronic Acid and Botulinum Toxin Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global Injectable Hyaluronic Acid and Botulinum Toxin Market Share by Application in 2022 & 2029
Figure 8. Cosmetic
Figure 9. Medical
Figure 10. Global Injectable Hyaluronic Acid and Botulinum Toxin Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 11. Global Injectable Hyaluronic Acid and Botulinum Toxin Market Size (2018-2029) & (US$ Million)
Figure 12. Global Injectable Hyaluronic Acid and Botulinum Toxin Sales (2018-2029) & (Units)
Figure 13. Global Injectable Hyaluronic Acid and Botulinum Toxin Average Price (US$/Unit) & (2018-2029)
Figure 14. Injectable Hyaluronic Acid and Botulinum Toxin Report Years Considered
Figure 15. Injectable Hyaluronic Acid and Botulinum Toxin Sales Share by Manufacturers in 2022
Figure 16. Global Injectable Hyaluronic Acid and Botulinum Toxin Revenue Share by Manufacturers in 2022
Figure 17. The Global 5 and 10 Largest Injectable Hyaluronic Acid and Botulinum Toxin Players: Market Share by Revenue in 2022
Figure 18. Injectable Hyaluronic Acid and Botulinum Toxin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 19. Global Injectable Hyaluronic Acid and Botulinum Toxin Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 20. North America Injectable Hyaluronic Acid and Botulinum Toxin Sales Market Share by Country (2018-2029)
Figure 21. North America Injectable Hyaluronic Acid and Botulinum Toxin Revenue Market Share by Country (2018-2029)
Figure 22. United States Injectable Hyaluronic Acid and Botulinum Toxin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 23. Canada Injectable Hyaluronic Acid and Botulinum Toxin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Europe Injectable Hyaluronic Acid and Botulinum Toxin Sales Market Share by Country (2018-2029)
Figure 25. Europe Injectable Hyaluronic Acid and Botulinum Toxin Revenue Market Share by Country (2018-2029)
Figure 26. Germany Injectable Hyaluronic Acid and Botulinum Toxin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. France Injectable Hyaluronic Acid and Botulinum Toxin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. U.K. Injectable Hyaluronic Acid and Botulinum Toxin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. Italy Injectable Hyaluronic Acid and Botulinum Toxin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Russia Injectable Hyaluronic Acid and Botulinum Toxin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Asia Pacific Injectable Hyaluronic Acid and Botulinum Toxin Sales Market Share by Region (2018-2029)
Figure 32. Asia Pacific Injectable Hyaluronic Acid and Botulinum Toxin Revenue Market Share by Region (2018-2029)
Figure 33. China Injectable Hyaluronic Acid and Botulinum Toxin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Japan Injectable Hyaluronic Acid and Botulinum Toxin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. South Korea Injectable Hyaluronic Acid and Botulinum Toxin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. India Injectable Hyaluronic Acid and Botulinum Toxin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. Australia Injectable Hyaluronic Acid and Botulinum Toxin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. China Taiwan Injectable Hyaluronic Acid and Botulinum Toxin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Indonesia Injectable Hyaluronic Acid and Botulinum Toxin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Thailand Injectable Hyaluronic Acid and Botulinum Toxin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Malaysia Injectable Hyaluronic Acid and Botulinum Toxin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Latin America Injectable Hyaluronic Acid and Botulinum Toxin Sales Market Share by Country (2018-2029)
Figure 43. Latin America Injectable Hyaluronic Acid and Botulinum Toxin Revenue Market Share by Country (2018-2029)
Figure 44. Mexico Injectable Hyaluronic Acid and Botulinum Toxin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Brazil Injectable Hyaluronic Acid and Botulinum Toxin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Argentina Injectable Hyaluronic Acid and Botulinum Toxin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Colombia Injectable Hyaluronic Acid and Botulinum Toxin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Middle East & Africa Injectable Hyaluronic Acid and Botulinum Toxin Sales Market Share by Country (2018-2029)
Figure 49. Middle East & Africa Injectable Hyaluronic Acid and Botulinum Toxin Revenue Market Share by Country (2018-2029)
Figure 50. Turkey Injectable Hyaluronic Acid and Botulinum Toxin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Saudi Arabia Injectable Hyaluronic Acid and Botulinum Toxin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. UAE Injectable Hyaluronic Acid and Botulinum Toxin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Global Sales Market Share of Injectable Hyaluronic Acid and Botulinum Toxin by Type (2018-2029)
Figure 54. Global Revenue Market Share of Injectable Hyaluronic Acid and Botulinum Toxin by Type (2018-2029)
Figure 55. Global Injectable Hyaluronic Acid and Botulinum Toxin Price (US$/Unit) by Type (2018-2029)
Figure 56. Global Sales Market Share of Injectable Hyaluronic Acid and Botulinum Toxin by Application (2018-2029)
Figure 57. Global Revenue Market Share of Injectable Hyaluronic Acid and Botulinum Toxin by Application (2018-2029)
Figure 58. Global Injectable Hyaluronic Acid and Botulinum Toxin Price (US$/Unit) by Application (2018-2029)
Figure 59. Injectable Hyaluronic Acid and Botulinum Toxin Value Chain
Figure 60. Injectable Hyaluronic Acid and Botulinum Toxin Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 医療美容におけるボツリヌス毒素の世界市場2023年：50U、100U、その他
  • 世界のタイプAボツリヌス毒素市場2022年：市場規模予測（～2028年）
  • ヒアルロン酸スプレーの世界市場2023年：150ml以下、150ml以上
  • 医療用ヒアルロン酸粘液補充の世界市場2023年：単回注射、複数回注射
  • 経口用ヒアルロン酸のグローバル市場展望 2023年-2029年：低分子量、高分子量
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(QYR23MA8796 )"注射用ヒアルロン酸＆ボツリヌス毒素の世界市場2023年：注射用ヒアルロン酸、ボツリヌス毒素" (英文：Global Injectable Hyaluronic Acid and Botulinum Toxin Market Research Report 2023)はQYResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。